Macy's will report its Q2 fiscal 2026 earnings on September 10, with analysts expecting adjusted EPS of $0.37 and net sales of $4.81 billion, both above company guidance. The retailer's turnaround strategy focuses on strengthening its core stores, growing luxury brands Bloomingdale's and Bluemercury, and monetizing supply-chain assets. Macy's has exceeded earnings expectations in recent quarters, and its current valuation metrics suggest it may be undervalued. Investors will watch the upcoming report and call for insights on the company's progress and outlook.
Macy's reported Q1 earnings per share of $0.40, exceeding the $0.37 estimate, with revenue of $4.87 billion beating expectations. Growth was driven by strong sales in Bloomingdale's, Bluemercury, and Macy's stores. The company raised its full-year ne...
Macy's reported second-quarter revenue of $4.9 billion, beating estimates, supported by $116 million in tariff refunds that boosted earnings. Adjusted EPS was $0.63 including $0.23 from refunds, surpassing expectations. The company raised its full-ye...
Macy's stock fell 5% after it reported better-than-expected Q2 earnings and raised its full-year outlook, driven partly by $116 million in tariff refunds. While revenue and profit beat estimates, the market reacted negatively because much of the earn...
Macy's reported strong second-quarter results with a 2.7% rise in comparable sales, driven by revamped stores and growth in Bloomingdale's and Bluemercury brands. The company raised its full-year net sales forecast to $21.68-$21.83 billion and earnin...
Myriad Uranium Corp. announced preliminary uranium assay results from drilling at the Gem deposit within its Copper Mountain Uranium Project in Wyoming. The drilling intersected multiple broad intervals of near-surface uranium mineralization, with th...
